Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, 430071, China.
Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan, 430071, China.
Biochem Biophys Res Commun. 2021 Apr 23;550:15-21. doi: 10.1016/j.bbrc.2021.02.125. Epub 2021 Mar 5.
Liver ischemia-reperfusion (IR) injury is an unavoidable pathological process in transplantation, closely related to poor prognosis. To date, there has been no clear therapeutic measure. We previously reported that mild hypothermia (MH), a widely used therapy, can exert significant protective effect against liver IR injury. Among the multiple mechanisms underlying the therapeutic effect of MH, autophagy flux drew our special attention. In this study, we evaluated the role of autophagy flux in IR injury and thereby explored the relationship between MH and autophagy flux in IR injury. We developed in vivo and in vitro models for hepatic IR injury. By autophagy flux assay with Western blotting and immunofluorescence, we found that MH restricts heavy accumulation of autophagosomes (APs) during IR injury. Activation and blocking of the autophagy flux unraveled that accumulation of APs further aggravated IR injury. Further, MH reduces APs accumulation to restore autophagy flux by regulating the fusion of APs and lysosomes. Besides, MH upregulated the level of Rab7 protein expression that was seriously impaired during IR injury. Inhibition of Rab7 expression increased apoptosis of liver cells and reduced the degree of overlap between APs and lysosomes. The results were reversed upon activation of Rab7. In conclusion, MH can alleviate liver IR injury by regulating the Rab7-mediated APs-lysosomes fusion that reduces APs accumulation. This can provide a theoretical basis for the further application of MH in related clinical diseases.
肝缺血再灌注(IR)损伤是移植中不可避免的病理过程,与预后不良密切相关。迄今为止,尚无明确的治疗措施。我们之前报道过,轻度低温(MH)是一种广泛应用的治疗方法,可对肝 IR 损伤发挥显著的保护作用。在 MH 治疗作用的多种机制中,自噬流引起了我们的特别关注。在这项研究中,我们评估了自噬流在 IR 损伤中的作用,从而探讨了 MH 与 IR 损伤中自噬流之间的关系。我们建立了体内和体外肝 IR 损伤模型。通过 Western blot 和免疫荧光自噬流检测,我们发现 MH 在 IR 损伤期间限制了自噬体(AP)的大量堆积。自噬流的激活和阻断揭示了 AP 的积累进一步加重了 IR 损伤。此外,MH 通过调节 AP 与溶酶体的融合来减少 AP 的积累以恢复自噬流。此外,MH 上调 Rab7 蛋白表达水平,该蛋白在 IR 损伤过程中严重受损。抑制 Rab7 表达增加了肝细胞的凋亡,并减少了 AP 与溶酶体之间的重叠程度。激活 Rab7 后,结果被逆转。总之,MH 通过调节 Rab7 介导的 AP-溶酶体融合来减轻肝 IR 损伤,从而减少 AP 的积累。这可为 MH 在相关临床疾病中的进一步应用提供理论依据。